Benzinga | Mar 10, 2021 08:04AM EST

Thermo Fisher Announces Over $600M In Capital Investments To Expand Bioprocessing Production

WALTHAM, Mass., March 10, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced more than $600 million in capital investments to expand its bioprocessing production capabilities through 2022. These investments are expected to more than double the company's current manufacturing capacity and support biopharma customers as they ramp up to meet both the short-term demands related to COVID-19 as well as long-term efforts to develop new vaccines and biologics for other conditions.